Hans-Peter Tony Selected Research

Hans-Peter Tony Research Topics

Disease

51	Rheumatoid Arthritis 10/2023 - 01/2005
10	Infections 01/2023 - 02/2009
6	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 06/2014
4	Necrosis 10/2023 - 06/2007
4	Giant Cell Arteritis (Horton Disease) 06/2023 - 01/2018
4	Pain (Aches) 09/2022 - 11/2016
4	Inflammation (Inflammations) 01/2022 - 09/2016
4	Rheumatic Diseases (Rheumatism) 11/2021 - 06/2008
3	Psoriatic Arthritis 06/2022 - 03/2016
3	Vasculitis (Vasculitides) 01/2018 - 05/2011
3	Autoimmune Diseases (Autoimmune Disease) 05/2011 - 03/2003
3	Lymphoma (Lymphomas) 04/2004 - 07/2003
2	Fatigue 09/2022 - 11/2016
2	Diffuse Scleroderma (Progressive Systemic Sclerosis) 10/2019 - 06/2014
2	Sepsis (Septicemia) 01/2018 - 06/2007
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2011 - 05/2010
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2011 - 07/2003
1	Nasopharyngitis 06/2023
1	Hypertension (High Blood Pressure) 06/2023
1	Back Pain (Backache) 04/2023
1	Axial Spondyloarthritis 04/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023
1	Opportunistic Infections (Opportunistic Infection) 01/2023
1	Primary Immunodeficiency Diseases 01/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 09/2022
1	Renal Insufficiency (Renal Failure) 09/2022
1	Coronary Disease (Coronary Heart Disease) 09/2022
1	Pulmonary Arterial Hypertension 01/2021
1	Common Variable Immunodeficiency 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2020
1	Autoimmune Diseases of the Nervous System 01/2020
1	Herpes Zoster 11/2019
1	Anaphylaxis (Anaphylactic Shock) 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	Crohn Disease (Crohn's Disease) 12/2018
1	T-Cell Lymphoma (Lymphoma, T Cell) 12/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2018
1	Persistent Infection 11/2018
1	Chronic Hepatitis C 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2018

Drug/Important Bio-Agent (IBA)

21	Rituximab (Mabthera)FDA Link 12/2022 - 01/2005
10	Antirheumatic Agents (DMARD)IBA 10/2023 - 01/2014
10	tocilizumab (atlizumab)FDA Link 06/2023 - 05/2011
9	Adalimumab (Humira)FDA Link 09/2020 - 09/2012
7	CytokinesIBA 01/2021 - 07/2003
7	AntibodiesIBA 01/2019 - 03/2003
7	AutoantibodiesIBA 01/2019 - 03/2003
5	Janus Kinase InhibitorsIBA 10/2023 - 04/2015
3	Prednisolone (Predate)FDA LinkGeneric 06/2023 - 06/2007
3	Interferon-gamma (Interferon, gamma)IBA 08/2021 - 07/2003
3	Biosimilar PharmaceuticalsIBA 01/2021 - 09/2017
3	Interleukin-6 (Interleukin 6)IBA 04/2016 - 05/2011
2	secukinumabIBA 06/2023 - 08/2021
2	GlucocorticoidsIBA 06/2023 - 09/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 04/2014
2	Leflunomide (Arava)FDA LinkGeneric 12/2022 - 11/2021
2	C-Reactive ProteinIBA 12/2022 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 11/2021
2	ametantrone (HAQ)IBA 09/2022 - 01/2019
2	tofacitinibIBA 11/2019 - 04/2015
2	3-benzoyl dopamine (MBDA)IBA 01/2019 - 09/2016
2	baricitinibIBA 01/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2017
2	Tumor Necrosis Factor InhibitorsIBA 12/2018 - 02/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 02/2009
2	Methotrexate (Mexate)FDA LinkGeneric 09/2017 - 03/2016
2	Immunoglobulin G (IgG)IBA 04/2016 - 11/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2014 - 06/2007
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2012 - 05/2011
2	AntigensIBA 05/2010 - 06/2007
2	DNA (Deoxyribonucleic Acid)IBA 05/2010 - 06/2007
2	nuclear pore protein p62IBA 05/2010 - 03/2003
2	SiliconesIBA 04/2004 - 09/2003
1	omega-Chloroacetophenone (Mace)IBA 10/2023
1	Abatacept (Orencia)FDA Link 09/2023
1	Monoclonal AntibodiesIBA 06/2023
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	Interleukin-17 (Interleukin 17)IBA 06/2022
1	ixekizumabIBA 06/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022
1	sarilumabIBA 01/2022
1	Contrast MediaIBA 08/2021
1	InterleukinsIBA 08/2021
1	Interleukin-9 (Interleukin 9)IBA 01/2021
1	Prostaglandins AIBA 05/2020
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2018
1	SteroidsIBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Bile Acids and Salts (Bile Acids)IBA 01/2018

Therapy/Procedure

24	Therapeutics 09/2023 - 07/2003
7	Hematopoietic Stem Cell Transplantation 01/2021 - 06/2014
3	Biological Therapy 10/2023 - 05/2015
3	Aftercare (After-Treatment) 08/2021 - 06/2014
2	Immunotherapy 01/2017 - 07/2003
1	Retreatment 12/2022
1	Transplantation 01/2021
1	Stem Cell Transplantation 01/2020
1	Salvage Therapy 01/2018
1	Vascular Surgical Procedures 01/2018